維爾利(300190.SZ):常州新北區壹號紓困已減持1.366555%的股份
格隆匯 7 月 14日丨維爾利(300190.SZ)公佈,公司於2020年7月14日收到常州新北區壹號紓困股權投資中心(有限合夥)出具的《簡式權益變動報告書》,獲悉常州新北區壹號紓困股權投資中心(有限合夥)於2020年7月13日通過大宗交易方式減持公司股份1071.0852萬股,佔公司總股份的1.366555%。
減持後,常州新北區壹號紓困股權投資中心(有限合夥)持有公司股份3918.9148萬股,佔公司總股份的4.999987%,常州新北區壹號紓困股權投資中心(有限合夥)不再是公司持股5%以上的股東。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.